INRLF Projected Dividend Yield
Ord/Valneva SE ( OTCBB : INRLF )Valneva is a vaccine biotech company encompassing research & development, manufacturing and commercialization to develop vaccines. Co.'s products include IXIARO® and JESPECT® that address Japanese encephalitis diseases. Co.'s other product is DUKORAL® a vaccine for cholera and Enterotoxigenic Escherichia coli bacterium. Co. is concentrating its research & development on the development of VLA15 vaccine against Lyme disease, which is a systemic infection caused by Borrelia bacteria transmitted to humans by infected Ixodes ticks. Co. is also progressing on its clinical development of Chikungunya vaccine VLA1553. Co.'s other vaccines in clinical development is Zika vaccine VLA1601. 20 YEAR PERFORMANCE RESULTS |
INRLF Dividend History Detail INRLF Dividend News INRLF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |